Eli Lilly participated in a $57.6m round that will support the identification and preclinical development of Cedilla's first two small molecule product candidates.

The networking technology startup increased its overall funding to $76m in a round led by Koch Disruptive Technologies and backed by GV.

Roivant Sciences, Cigna Ventures and Johnson & Johnson Innovation – JJDC helped push the healthcare data exchange's overall funding to $83m.

Cisco, Microsoft and Citi all returned to lift cybersecurity technology provider Illusive Networks' total funding to $54m.

Bonnier Ventures co-led a $17.8m round for the Chalmers Ventures-backed employee engagement platform developer that will support international growth.

Existing investor Lilly Asia Ventures helped the genome editing technology developer push its overall funding past the $100m mark.

Bonnier Ventures co-led a $17.8m round for the employee engagement platform developer that will support international growth.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

UC Investments has backed cancer cell therapy developer A2 Biotherapeutics, bringing the company's total funding to $136m.

Oncology therapy developer A2 Biotherapeutics raised $71.5m from investors including Hartford HealthCare Endowment to take its funding to $136m altogether.